RARECELLSDETECT AND DEFEAT CANCER FROM ITS START THROUGH A SIMPLE BLOOD DRAWMOREISET® PLATFORMVERSATILITY, SENSITIVITY INTACT LABEL-FREE FIXED AND LIVING CELLS FROM A BLOOD DRAWMOREAPPLICATIONSFOSTER YOUR RESEARCH STUDIES ACCESSING THE RIGHT CIRCULATING TUMOR CELLS & CTC DNAMORE Previous Next RARECELLSOUTSMARTING CANCER FROM ONSET TO REMISSIONMOREISET® PLATFORMVERSATILITY, SENSITIVITY INTACT LABEL-FREE FIXED AND LIVING CELLS FROM A BLOOD DRAWMOREAPPLICATIONSFOSTER YOUR RESEARCH STUDIES ACCESSING THE RIGHT CIRCULATING TUMOR CELLS & CTC DNAMORE Previous Next RARECELLSDETECT AND DEFEAT CANCER FROM ITS START THROUGH A SIMPLE BLOOD DRAWMOREISET® PLATFORMVERSATILITY, SENSITIVITY INTACT LABEL-FREE FIXED AND LIVING CELLS FROM A BLOOD DRAWMOREAPPLICATIONSBOOST YOUR RESEARCH STUDIES ACCESSING THE RIGHT CIRCULATING TUMOR CELLS & CTC DNAMORE RARECELLS FROM RESEARCH TO CLINIC From a 10mL blood draw, ISET® system is capturing intact CTC ready for downstream analysis from cytology to DNA analysis. ISET® isolated CTC, a reliable source to foster research applied to early detection, prognosis, and theranostic Learn more about the ISET® cytology blood test ANY QUESTIONS? NEED FOR INFORMATION? CONTACT US LEARN ABOUT ISET TECHNOLOGY AND CTC NEWS Press release : Rarecells, Inc. announces successful Series A funding, reaching $13 Million raised to develop Liquid Biopsy Early Cancer Detection Tests READ MORE » December 9, 2021 Press release : Rarecells, Inc. to fund a clinical study at Columbia University of its ISET® -AML test for early detection of Acute Myeloid Leukemia (AML) READ MORE » November 10, 2021 Prof. Patrizia Paterlini-Brechot – Rarecells, Inc. – embarks on the search for the First Cell to beat cancer READ MORE » April 15, 2021
Press release : Rarecells, Inc. announces successful Series A funding, reaching $13 Million raised to develop Liquid Biopsy Early Cancer Detection Tests READ MORE » December 9, 2021
Press release : Rarecells, Inc. to fund a clinical study at Columbia University of its ISET® -AML test for early detection of Acute Myeloid Leukemia (AML) READ MORE » November 10, 2021
Prof. Patrizia Paterlini-Brechot – Rarecells, Inc. – embarks on the search for the First Cell to beat cancer READ MORE » April 15, 2021